Cargando…
Mechanism of Action and Structure–Activity Relationships of Tetracyclic Small Molecules Acting as Universal Positive Allosteric Modulators of the Cholecystokinin Receptor
As part of an ongoing effort to develop a drug targeting the type 1 cholecystokinin receptor (CCK1R) to help prevent and/or treat obesity, we recently performed a high throughput screening effort of small molecules seeking candidates that enhanced the action of the natural agonist, CCK, thus acting...
Autores principales: | Dengler, Daniela G., Harikumar, Kaleeckal G., Yen, Alice, Sergienko, Eduard A., Miller, Laurence J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964746/ https://www.ncbi.nlm.nih.gov/pubmed/36837653 http://dx.doi.org/10.3390/membranes13020150 |
Ejemplares similares
-
Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity
por: Dengler, Daniela G., et al.
Publicado: (2022) -
Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol
por: Harikumar, Kaleeckal G., et al.
Publicado: (2021) -
Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics
por: Miller, Laurence J., et al.
Publicado: (2021) -
Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivity
por: Mobbs, Jesse I., et al.
Publicado: (2021) -
First Metal-Free Synthesis of Tetracyclic Pyrido and Pyrazino Thienopyrimidinone Molecules
por: Aounzou, Mohammed, et al.
Publicado: (2018)